Characteristics of the COVID-19 Epidemiological Situation in the Russian Federation in 2020

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The COVID-19 epidemic in the Russian Federation, which began in March 2020, caused serious damage to health of the population and led to severe economic losses. By December 28, 2020, 3 078 035 cases of COVID-19 and 55 265 lethal outcomes were registered in the country. The population of all territorial subjects of the country is involved in the epidemic process of COVID-19. The severe epidemiological situation made it necessary to conduct an analysis to identify the factors that determine the high intensity of the epidemic process, as well as the population groups with the highest risk of SARS-CoV-2 infection. 

Aims — to study the patterns of SARS-CoV-2 spread and the epidemiological features of the initial stage of the COVID-19 pandemic in the Russian Federation in 2020. 

Methods. An epidemiological analysis of the COVID-19 situation in the Russian Federation was carried out to determine the dynamics of morbidity, the gender proportion and age structure of patients, the proportion of hospitalized patients, the ratio of various forms of infection, the social and professional status of patients. Standard methods of descriptive statistics Microsoft Excel and STATISTICA 12.0 (StatSoft, USA) were used for statistical processing. The mean values were estimated with a 95% confidence interval [95% CI] (the exact Klopper – Pearson method). 

Results. During the observation time (2020), several periods were identified in the dynamics of the new COVID-19 cases detection: the period of importation of SARS-CoV-2 and the increase in morbidity, the period of epidemic decline, the period of autumn growth, the period of sustained high incidence of COVID-19. It was found that people over 70 years of age are the group with the highest risk of infection and a more severe course of COVID-19. The presence of target contingents among social and professional groups of the population, which should include medical workers, retired person, employees of educational institutions, law enforcement agencies, transport, who require special attention and medical and social support, was shown. 

Conclusions. The analysis showed that the large-scale spread of COVID-19 requires in-depth epidemiological studies and the development of additional disease control measures, taking into account the dynamics of the incidence of this socially significant infection.

Full Text

Restricted Access

About the authors

Vasiliy G. Akimkin

Central Research Institute for Epidemiology

Author for correspondence.
Email: akimkin@pcr.ms
ORCID iD: 0000-0003-4228-9044
SPIN-code: 4038-7455

MD, PhD, Academician of the RAS

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Stanislav N. Kuzin

Central Research Institute for Epidemiology

Email: drkuzin@list.ru
ORCID iD: 0000-0002-0616-9777
SPIN-code: 1372-7623

MD, PhD, Professor

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Tatyana A. Semenenko

National Research Centre for Epidemiology and Microbiology Named After the Honorary Academician N.F. Gamaleya

Email: semenenko@gamaleya.org
ORCID iD: 0000-0002-6686-9011
SPIN-code: 8375-2270

MD, PhD, Professor

Russian Federation, Moscow

Antonina A. Ploskireva

Central Research Institute for Epidemiology

Email: zdk@pcr.ru
ORCID iD: 0000-0002-3612-1889
SPIN-code: 1364-1257

MD, PhD

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Dmitriy V. Dubodelov

Central Research Institute for Epidemiology

Email: dubodelov@cmd.su
ORCID iD: 0000-0003-3093-5731
SPIN-code: 4860-7909

MD, PhD, Senior Research Associate

Russian Federation, 3A, Novogireyevskaya street, Moscow

Elena V. Tivanova

Central Research Institute for Epidemiology

Email: tivan@cmd.su
ORCID iD: 0000-0003-1286-2612
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Natalia Yu. Pshenichcnaya

Central Research Institute for Epidemiology

Email: pshenichnaya@cmd.su
ORCID iD: 0000-0003-2570-711X
SPIN-code: 5633-7265

MD, PhD

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Anna V. Kalenskaya

Central Research Institute for Epidemiology

Email: kalenskaya@cmd.su
ORCID iD: 0000-0002-9126-1155
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Svetlana B. Yatsyshina

Central Research Institute for Epidemiology

Email: svetlana.yatsyshina@pcr.ms
ORCID iD: 0000-0003-4737-941X
SPIN-code: 7156-2948

PhD in Biology, Senior Research Associate

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Olga Yu. Shipulina

Central Research Institute for Epidemiology

Email: olga.shipulina@pcr.ms
ORCID iD: 0000-0003-4679-6772
SPIN-code: 9235-1239

MD, PhD

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Elena N. Rodionova

Central Research Institute for Epidemiology

Email: rodionova@cmd.su
ORCID iD: 0000-0003-0192-1832

MD, PhD

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Natalya S. Petrova

Central Research Institute for Epidemiology

Email: petrova@cmd.su
ORCID iD: 0000-0003-0166-555X

PhD in Biology

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Irina V. Soloveva

Central Research Institute for Epidemiology

Email: soloviovaiv@cmd.su
ORCID iD: 0000-0002-3136-9500
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Olga A. Kvasova

Central Research Institute for Epidemiology

Email: kvasova@cmd.su
ORCID iD: 0000-0002-4545-1804
SPIN-code: 2082-4851
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Marina A. Vershinina

Central Research Institute for Epidemiology

Email: vershinina@cmd.su
ORCID iD: 0000-0001-8582-5199
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Marina V. Mamoshina

Central Research Institute for Epidemiology

Email: grya@cmd.su
ORCID iD: 0000-0002-1419-7807
SPIN-code: 7123-8874

junior research associate

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Vitalina V. Klushkina

Central Research Institute for Epidemiology

Email: klishkina@cmd.su
ORCID iD: 0000-0001-8311-8204
SPIN-code: 8008-7924

MD, PhD

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Elena N. Kudryavceva

Central Research Institute for Epidemiology

Email: kudravtseva@cmd.su
ORCID iD: 0000-0002-7325-8577
SPIN-code: 6487-9964

PhD in Biology

Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Nadezhda S. Churilova

Central Research Institute for Epidemiology

Email: churilova@cmd.su
ORCID iD: 0000-0001-5344-5829
SPIN-code: 8657-9687
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Yarina V. Panasyuk

Central Research Institute for Epidemiology

Email: panasyuk@cmd.su
ORCID iD: 0000-0002-9335-4953
SPIN-code: 8983-7979
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Natal'ya V. Vlasenko

Central Research Institute for Epidemiology

Email: vlasenko@cmd.su
ORCID iD: 0000-0002-2388-1483
SPIN-code: 1933-5968
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Aleksey A. Ostroushko

Central Research Institute for Epidemiology

Email: ostroushko@cmd.su
ORCID iD: 0000-0003-0803-5630
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Evgeniy S. Balmasov

Central Research Institute for Epidemiology

Email: balmasov@cmd.su
ORCID iD: 0000-0003-3382-2441
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

Artem V. Mosunov

Central Research Institute for Epidemiology

Email: mosunov@cmd.su
ORCID iD: 0000-0001-6743-3650
Russian Federation, 3A, Novogireyevskaya street, Moscow, 111123

References

  1. Акимкин В.Г., Кузин С.Н., Семененко Т.А., и др. Закономерности эпидемического распространения SARS-CoV-2 в условиях мегаполиса // Вопросы вирусологии. — 2020. — Т. 65. — № 4. — С. 203–211. [Akimkin VG, Kuzin SN, Semenenko TA, et al. Patterns of the SARS-CoV-2 epidemic spread in a megacity. Problems of Virology (Voprosy virusologii). 2020;65(4):203–211. (In Russ.)] doi: https://doi.org/10.36233/0507-4088-2020-65-4-203-211
  2. Акимкин В.Г., Кузин С.Н., Семененко Т.А., и др. Гендерно-возрастная характеристика пациентов с COVID-19 на разных этапах эпидемии в Москве // Проблемы особо опасных инфекций. — 2020. — № 3. — С. 27–35. [Akimkin VG, Kuzin SN, Semenenko TA, et al. Gender-Age Distribution of Patients with COVID-19 at Different Stages of Epidemic in Moscow. Problemy Osobo Opasnykh Infektsii = Problems of Particularly Dangerous Infections. 2020;(3):27–35. (In Russ.)] doi: https://doi.org/10.21055/0370-1069-2020-3-27-35
  3. Кутырев В.В., Попова А.Ю., Смоленский В.Ю., и др. Эпидемиологические особенности новой коронавирусной инфекции (COVID-19). Сообщение 2: особенности течения эпидемического процесса COVID-19 во взаимосвязи с проводимыми противоэпидемическими мероприятиями в мире и Российской Федерации // Проблемы особо опасных инфекций. — 2020. — № 2. — С. 6–12. [Kutyrev VV, Popova AYu, Smolenskiy VYu, et al. Epidemiological Peculiarities of New Coronavirus Infection (COVID-2019). Communication 2: Peculiarities of epidemic process development in conjunction with performed anti-epidemic measures around the world and in the Russian Federation. Problemy Osobo Opasnykh Infektsii = Problems of Particularly Dangerous Infections. 2020;(2):6–12. (In Russ.)] doi: https://doi.org/10.21055/0370-1069-2020-2-6-12
  4. Bimonte S, Crispo A, Amore A, et al. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In Vivo. 2020;34(3Suppl):1597–1602. doi: https://doi.org/10.21873/invivo.11949
  5. Martinez MA. Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Antimicrob Agents Chemother. 2020;64(9):e01101–e01120. doi: https://doi.org/10.1128/AAC.01101-20
  6. Agrawal S, Goel AD, Gupta N. Emerging prophylaxis strategies against COVID-19. Monaldi Arch Chest Dis. 2020;90(1). doi: https://doi.org/10.4081/monaldi.2020.1289
  7. Henning U, Micheli MP. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement. Stem Cell Rev Rep. 2020;16(3):434–440. doi: https://doi.org/10.1007/s12015-020-09976-7
  8. Casares M, Khan H. The Timing and Intensity of Social Distancing to Flatten the COVID-19 Curve: The Case of Spain. Int J Environ Res Public Health. 2020;17(19):E7283. doi: https://doi.org/10.3390/ijerph17197283
  9. Zongo P, Zorom M, Mophou G, et al. A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France. Epidemiol Infect. 2020;148:e221. doi: https://doi.org/10.1017/S0950268820002162
  10. Kaur S, Sonali S. India fights COVID-19. Review Psychol Trauma. 2020;12(6):579–581. doi: https://doi.org/10.1037/tra0000615
  11. Brooks ZC, Das S. COVID-19 Testing. Am J Clin Pathol. 2020;154(5):575–584. doi: https://doi.org/10.1093/ajcp/aqaa141
  12. Qeadan F, Mensah NA, Tingey B, et al. What Protective Health Measures Are Americans Taking in Response to COVID-19? Results from the COVID Impact Survey. Int J Environ Res Public Health. 2020;17(17):6295. doi: https://doi.org/10.3390/ijerph17176295
  13. da Silva LLS, Lima AFR, Polli DA, et al. Social distancing measures in the fight against COVID-19 in Brazil: description and epidemiological analysis by state. Cad Saude Publica. 2020;36(9):e00185020. doi: https://doi.org/10.1590/0102-311X00185020
  14. Banerjee A, Pasea L, Harris S, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet. 2020; 395(10238):1715–1725. doi: https://doi.org/10.1016/S0140-6736(20)30854-0
  15. Promislow DEL. A Geroscience Perspective on COVID-19 Mortality. J Gerontol A Biol Sci Med Sci. 2020;75(9):e30–e33. doi: https://doi.org/10.1093/gerona/glaa094
  16. Hur K, Price CPE, Gray EL, et al. Factors Associated with Intubation and Prolonged Intubation in Hospitalized Patients with COVID-19. Otolaryngol Head Neck Surg. 2020;163(1):170–178. doi: https://doi.org/10.1177/0194599820929640
  17. Bravi F, Flacco ME, Carradori T, et al. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens. PLoS One. 2020;15(6):e0235248. doi: https://doi.org/10.1371/journal.pone.0235248
  18. do Nascimento IJB, von Groote TC, O’Mathúna DP, et. al. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses. PLoS One. 2020;15(9):e0239235. doi: https://doi.org/10.1371/journal.pone.0239235
  19. Flint AJ, Bingham KS, Iaboni A. Effect of COVID-19 on the mental health care of older people in Canada. 2020;32(10):1113–1116. doi: https://doi.org/10.1017/S1041610220000708
  20. van Tilburg TG, Steinmetz S, Stolte E, et al. Loneliness and mental health during the COVID-19 pandemic: A study among Dutch older adults. J Gerontol B Psychol Sci Soc Sci. 2020;76(7):e249–e255. doi: https://doi.org/10.1093/geronb/gbaa111
  21. García-Fernández L, Romero-Ferreiro V, López-Roldán PD, et al. Mental Health in Elderly Spanish People in Times of COVID-19 Outbreak. Am J Geriatr Psychiatry. 2020;28(10):1040–1045. doi: https://doi.org/10.1016/j.jagp.2020.06.027
  22. Skoog I. COVID-19 and mental health among older people in Sweden. Int Psychogeriatr. 2020;32(10):1173–1175. doi: https://doi.org/10.1017/S104161022000143X
  23. Nwachukwu I, Nkire N, Shalaby R, et al. COVID-19 Pandemic: Age-Related Differences in Measures of Stress, Anxiety and Depression in Canada. Int J Environ Res Public Health. 2020;17(17):6366. doi: https://doi.org/10.3390/ijerph17176366
  24. Saurabh S, Verma MK, Gautam V, et al. Transmission Dynamics of the COVID-19 Epidemic at the District Level in India: Prospective Observational Study. JMIR Public Health Surveill. 2020;6(4):e22678. doi: https://doi.org/10.2196/22678
  25. Spinazzè A, Cattaneo A, Cavallo DM. COVID-19 Outbreak in Italy: Protecting Worker Health and the Response of the Italian Industrial Hygienists Association. Ann Work Expo Health. 2020;64(6):559–564. doi: https://doi.org/10.1093/annweh/wxaa044
  26. Firew T, Sano ED, Lee JW, et al. Protecting the front line: a cross-sectional survey analysis of the occupational factors contributing to healthcare workers’ infection and psychological distress during the COVID-19 pandemic in the USA. BMJ Open. 2020;10(10):e042752. doi: https://doi.org/10.1136/bmjopen-2020-042752
  27. Yoshida I, Tanimoto T, Schiever N, et al. Characteristics of doctors’ fatality due to COVID-19 in Western Europe and Asia-Pacific countries. QJM. 2020;113(10):713–714. doi: https://doi.org/10.1093/qjmed/hcaa159
  28. Ren Y, Feng C, Rasubala L, et al. Risk for dental healthcare professionals during the COVID-19 global pandemic: An evidence-based assessment. Dent. 2020;101:103434. doi: https://doi.org/10.1016/j.jdent.2020.103434
  29. Ahmad N. COVID-19 Modeling in Saudi Arabia Using the Modified Susceptible-Exposed-Infectious-Recovered (SEIR) Model. Cureus. 2020;12(9):e10452. doi: https://doi.org/10.7759/cureus.10452
  30. Nienhaus A., Hod R. COVID-19 among Health Workers in Germany and Malaysia. Int J Environ Res Public Health. 2020;17(13):4881. doi: https://doi.org/10.3390/ijerph17134881

Supplementary files

Supplementary Files
Action
1. Fig. 1. Dynamics of registration of new cases (abs.) Among the population of the Russian Federation

Download (274KB)
2. Fig. 2. The ratio of patients with COVID-19 of different age groups in the Russian Federation from March 6 to October 22, 2020.

Download (153KB)

Copyright (c) 2021 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies